UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000020855
Receipt number R000023307
Scientific Title Phase II study of nivolumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy
Date of disclosure of the study information 2016/02/03
Last modified on 2023/02/12 10:07:24

No. Disposal Last modified on Item of update
1 Insert 2016/02/02 23:31:30
2 Update 2016/02/13 21:53:55 Recruitment status
3 Update 2016/04/01 15:14:55 Name of primary person or sponsor
Organization
4 Update 2016/04/07 23:34:29 Name of primary person or sponsor
Organization
5 Update 2016/04/07 23:38:46 Name of primary person or sponsor
Organization
6 Update 2016/04/07 23:42:43 Organization
Institute
Organization
7 Update 2016/09/28 12:39:21 Public title
Acronym
8 Update 2016/09/28 12:39:51 Narrative objectives1
9 Update 2016/11/27 22:47:21 Key inclusion criteria
Key inclusion criteria
10 Update 2016/11/27 22:51:32 Narrative objectives1
Narrative objectives1
11 Update 2016/11/27 22:52:06 Public title
Public title
12 Update 2016/11/27 22:52:42 Key inclusion criteria
Key inclusion criteria
13 Update 2016/11/27 22:54:34 Public title
Public title
14 Update 2016/12/16 00:17:11 Key secondary outcomes
Key secondary outcomes
15 Update 2016/12/17 00:06:46 Study ID_1
Org. issuing International ID_1
16 Update 2018/01/11 22:57:11 Recruitment status
17 Update 2019/03/22 12:37:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
18 Update 2019/03/22 12:38:02 Number of participants that the trial has enrolled
19 Update 2019/03/22 12:40:46 Date of IRB
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
20 Update 2023/02/12 10:07:24 Results Delayed
Results Delay Reason
Results Delay Reason